Rani Therapeutics Holdings Cash Flow Statement (2020-2026) | RANI

Cash Flow Statement Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Operating Activities
Net Income (Quarter)
-5.49M-28.70M-13.30M-13.83M-15.97M-16.21M-17.34M-16.83M-18.66M-18.33M-14.05M-14.78M-13.36M-12.72M-15.72M-12.74M-11.22M-7.91M-8.50M-8.02M
Depreciation and Depletion (Quarter)
0.13M0.12M0.12M0.11M0.12M0.14M0.13M0.30M0.20M
Share-based Compensation (Quarter)
0.28M18.70M3.16M2.90M3.98M4.40M4.50M4.42M5.14M4.97M4.49M3.87M4.13M4.04M3.99M3.92M3.29M2.34M2.24M2.08M
Gains from Sales and Divestitures (Quarter)
0.02M0.02M0.02M0.03M0.27M0.04M0.03M0.02M0.39M0.16M0.22M0.27M0.33M0.12M
Gains from Investment Securities (Quarter)
2.29M0.09M0.04M0.06M0.11M0.16M-0.16M0.48M0.01M13.49M12.87M-0.04M0.03M
Non-cash Items (Quarter)
0.06M0.98M0.13M0.60M0.85M13.38M0.03M5.67M6.46M6.40M7.18M7.77M
Cash from Operations (Quarter)
-5.63M-11.12M-11.45M-9.36M-10.33M-12.20M-14.63M-12.15M-12.30M-14.30M-12.48M-9.40M-9.03M-8.41M-8.65M-8.15M-5.75M-5.11M0.31M-6.50M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)
0.16M0.16M-0.11M0.55M0.26M0.26M0.26M1.54M0.34M0.14M0.85M0.48M0.15M0.01M0.12M0.24M
Amortization of Deferred Charges (Quarter)
0.02M0.06M0.06M0.06M0.06M0.06M0.06M0.06M0.06M0.06M0.06M0.06M0.06M0.03M
Depreciation & Amortization (CF) (Quarter)
0.13M0.12M0.11M0.11M0.12M0.14M0.17M0.19M0.19M0.22M0.23M0.25M0.26M0.26M0.27M0.25M0.24M0.22M0.19M0.16M
Change in Working Capital
Change in Receivables (Quarter)
0.60M-1.03M2.47M
Change in Account Payables (Quarter)
0.54M-0.06M-0.13M0.08M0.13M0.17M-0.21M0.08M-0.41M0.40M-0.66M0.16M-0.30M1.06M-0.21M0.16M0.28M0.67M-2.16M0.55M
Change in Accured Expenses (Quarter)
0.73M0.79M-1.61M0.65M0.80M0.94M-1.78M0.32M1.38M-0.08M-2.17M0.88M-0.20M-0.63M0.29M0.17M0.39M-0.55M3.18M0.76M
Investing Activities
Capital Expenditures (Quarter)
-0.10M0.23M-0.09M0.25M0.09M0.75M0.53M0.09M-0.05M0.21M0.98M0.05M0.06M0.12M0.03M0.09M0.01M
Change in Acquisitions & Divestments (Quarter)
3.00M23.00M35.00M23.50M22.85M20.35M18.20M18.70M20.30M21.00M5.75M21.00M
Cash from Investing Activities (Quarter)
-0.14M-0.27M-0.25M-0.38M-71.35M-0.46M4.12M0.79M11.67M13.27M10.29M6.53M0.47M2.52M18.23M5.71M-30.97M-2.45M
Financing Activities
Other financing activities (Quarter)
2.19M-1.89M0.11M0.15M
Debt Issuance and Repayment
Long-Term Debt Issuances (Quarter)
-1.72M1.72M14.67M14.90M
Long-Term Debt Repayments (Quarter)
1.25M3.75M3.75M3.75M3.75M9.47M
Change in Capital Stock
Shares Issued (Quarter)
-0.01M0.03M0.05M-0.15M0.13M-0.13M0.08M-0.08M0.12M-0.08M8.88M-0.39M0.04M3.90M-3.53M0.01M
Preferred Shares Issued (Quarter)
Misc.
Cash from Financing Activities (Quarter)
-1.58M71.55M-0.57M0.05M14.08M14.87M0.01M0.08M0.05M0.10M0.12M0.14M7.70M5.62M-3.73M0.19M-1.01M44.85M-0.03M
Change in Cash (Quarter)
-7.35M60.43M-12.29M-9.61M-10.66M-69.46M-0.21M-8.02M-11.43M-2.58M0.89M1.01M-2.36M-0.24M-0.52M6.35M0.10M-6.07M14.17M-8.97M
Free Cash Flow (Quarter)
-5.53M-11.36M-11.36M-9.61M-10.41M-12.95M-15.16M-12.24M-12.25M-14.52M-13.46M-9.45M-9.09M-8.54M-8.69M-8.15M-5.84M-5.11M0.31M-6.51M
Net Cash Flow (Quarter)
-7.35M60.43M-12.29M-9.61M-10.66M-69.46M-0.21M-8.02M-11.43M-2.58M0.89M1.01M-2.36M-0.24M-0.52M6.35M0.15M-6.12M14.19M-8.98M